Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

BIOSYENT INC V.RX

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Major
Alternate Symbol(s):  BIOYF

Biosyent Inc is a life science company engaged in marketing of pharmaceutical products & manufacturing & marketing of non-chemical bio & health-friendly insecticides. It acquires or license products & commercializes technology to health & public safety.
Price: $9.52 | Change: +$0.07 | %Change: +0.74%
Volume: 8,970 | Day High/Low: 9.52/9.37 | 52 Week High/Low: 12.82/4.72
View modes: 
3.5 stars

A few thoughts about Q1...

I'm inclined to think that Q1 should be quite good, for the following reasons: 1. Every quarter is good.  For years now, RX's track record for sequential and year-over-year pharma growth has been...read more
0 stars

RE:Michael Smedley on BNN on RX today

Slow and steady - was hoping he'd give us update on the new product sales launched in December and how the new shiringe sales were coming along since February. Picked more up on the latest dip in the ...read more
0 stars

RE:Michael Smedley on BNN on RX today

Here's the direct link (second question). GLTA http://www.bnn.ca/Video/player.aspx?vid=577124 2015-03-24 BUY Michael Smedley Very steady, careful accumulator of products to market in Canada...read more
0 stars

Michael Smedley on BNN on RX today

Very stable, he still holds http://www.bnn.ca/Shows/Market-Call-Tonight.aspx  rate and reply
3 stars

TSX over 15,000......

The TSX climbed  over 15,000 today , closing at 15,081.26. The TSX Venture on the other hand sits near its all time lows. The TSX reached a high of 15,685.13 on Sept. 03,2014 The TSX Venture...read more
0 stars

RE:Poised for a great 2015, says Cantor Fitzgerald Canada

Looks like Cantor follows its own advice (Broker code =4)  rate and reply
0 stars

Bought some today

Y it could fall more but in a year?  rate and reply
0 stars

RE:RE:Drop in stock price

Thanks for the insight investor22, much appreciated.  rate and reply
3 stars

RE:Drop in stock price

Solid: The price is the same as it was before earnings were released, although I can understand why you might be a little frustrated.   With all the positives here - none of the currently marketed 6...read more
0 stars

Drop in stock price

Why has Rx drop so significantly after good earnings report, can someone please explain the cause of this, not sure if the insiders are playing games trying to buy back their stock?  rate and reply
0.5 stars

Difference between RX and CRX

I would like opinions on the difference between the 2 companies. I guess both are into the acquisition of phama products. Reading RX press releases look like the company is more into acquiring patents...read more
3.5 stars

CXR makes $1.2 billion acquisition

RX niche is intact http://www.newswire.ca/en/story/1498485/concordia-healthcare-corp-to-acquire-covis-pharma-commercial-assets-for-us-1-2-billion  rate and reply
0 stars

Cantech Letter

Extract from a post by CQCmaster. GLTA The two best examples that come to my mind are: Paladin Labs and BioSyent (OTCPK:BIOYF). Former pharma sales rep., and Cantech Letter contributor Hogan...read more
0 stars

RE:RE:RE:Definately on the buyout list

I think it's more of a general frustration with the VSX. Although there are still some good stocks on that exchange (RX being one of them), it has been an absolute wasteland since 2008 so most...read more
0 stars

RE:RE:Definately on the buyout list

DoctorKP wrote: I agree but maybe a move to TSX will benefit this stock Does anyone else notice that the strategy, valuation or general fundamentals of companies are rarely discussed in favor of...read more
0 stars

RE:Definately on the buyout list

I agree but maybe a move to TSX will benefit this stock  rate and reply
0 stars

RE:Poised for a great 2015, says Cantor Fitzgerald Canada

Thanks for that, Sir_H. By the way, if anyone hasn't yet seen the company's Q4 presentation, I highly recommend they do so.  Lots of interesting (and compelling) new info is contained therein.  rate and reply
5 stars

Poised for a great 2015, says Cantor Fitzgerald Canada

http://www.cantechletter.com/2015/02/biosyent-poised-great-2015-says-cantor-fitzgerald-canada/  rate and reply
0 stars

Definately on the buyout list

Though i'll take all cap appreciation. Been building a new base and on any news will reach the $12.50 - $13.50 range per many analyst targets. Even the big original believers like Smedley and...read more
0 stars

RE:RE:Congratulations

Easy, I am also long RX and EFN. Awesome day for RX. Its still a buy at this level in my books, I will be adding more. As for EFN, numbers look good, I am hoping it jumps to $17 or $16.50 on the news....read more